Key Points
- CFO Fawwad Qureshi executed insider sales totaling 7,482 shares (2,837 on Feb 27 at $26.46 and 4,645 on Feb 25 at $25.61), generating roughly $194,025 in proceeds.
- Trupanion reported Q4 EPS of $0.13 (missing by $0.01) with revenue up 11.7% to $376.85M; the stock is near its 12‑month low ($25.24), carries a consensus "Hold" rating and an average analyst target of $45.50 after recent price-target cuts.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CFO Fawwad Qureshi sold 2,837 shares of Trupanion stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $26.46, for a total value of $75,067.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Fawwad Qureshi also recently made the following trade(s):
- On Wednesday, February 25th, Fawwad Qureshi sold 4,645 shares of Trupanion stock. The stock was sold at an average price of $25.61, for a total transaction of $118,958.45.
Trupanion Stock Performance
TRUP opened at $27.46 on Wednesday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. Trupanion, Inc. has a 12-month low of $25.24 and a 12-month high of $57.88. The company has a market cap of $1.19 billion, a price-to-earnings ratio of 61.02 and a beta of 1.62. The company's 50 day moving average is $32.51 and its 200 day moving average is $38.21.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.01). The company had revenue of $376.85 million for the quarter, compared to the consensus estimate of $375.89 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The business's revenue for the quarter was up 11.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.04 EPS. On average, equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.
Analyst Upgrades and Downgrades
TRUP has been the topic of a number of research reports. Cantor Fitzgerald cut their target price on shares of Trupanion from $50.00 to $42.00 and set a "neutral" rating on the stock in a research report on Wednesday, January 14th. Wall Street Zen cut shares of Trupanion from a "buy" rating to a "hold" rating in a report on Saturday, December 6th. Piper Sandler reduced their price objective on Trupanion from $60.00 to $45.00 and set an "overweight" rating on the stock in a research report on Friday, February 13th. Zacks Research lowered shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 13th. Finally, Weiss Ratings raised Trupanion from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Tuesday, February 17th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $45.50.
View Our Latest Stock Report on Trupanion
Institutional Investors Weigh In On Trupanion
Institutional investors and hedge funds have recently modified their holdings of the stock. Federated Hermes Inc. bought a new position in shares of Trupanion during the 3rd quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Trupanion during the 3rd quarter worth approximately $39,000. Nisa Investment Advisors LLC raised its stake in shares of Trupanion by 44.1% in the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider's stock valued at $54,000 after purchasing an additional 300 shares in the last quarter. Kelleher Financial Advisors acquired a new position in shares of Trupanion in the third quarter valued at $74,000. Finally, Kemnay Advisory Services Inc. acquired a new stake in Trupanion during the fourth quarter worth $64,000.
About Trupanion
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
